Innate Pharma S.A. ADS — Chart, Price & News (NASDAQ:IPHA) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Market Capitalization N/A
Employee 174
Founded 1999
CEO N/A
Website www.innate-pharma.com
Headquarter France
FIGI BBG009ZCBVG7
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

— Market capitalization

Price to earnings ratio

—

Price to sales ratio

—

Dividends per share

—

Dividend yield %

—

Nouvelles

Innate Pharma S.A. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:IPHA) 2025-11-15

Pourquoi les actions de Rocket Lab sont échangées en hausse de plus de 9% ; Voici 20 actions qui bougent avant l'ouverture du marché | Benzinga France

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - BigBear.ai Hldgs (NYSE:BBAI), Aspire Biopharma Hldgs (NASDAQ:ASBP)

Innate Pharma (IPHA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Cet analyste d'Edwards Lifesciences devient optimiste ; voici les 4 meilleures améliorations pour mercredi | Benzinga France

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Edwards Lifesciences (NYSE:EW), Brookfield Infr Partners (NYSE:BIP)

Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript

Innate Pharma S.A. (IPHA) Analyst/Investor Day - Slideshow (NASDAQ:IPHA) 2025-10-28

Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call Transcript

Innate Pharma stock initiated with Buy rating at BTIG on cancer therapy potential

Innate Pharma stock surges on promising preclinical data

French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit - Sanofi (NASDAQ:SNY)